BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19007562)

  • 1. [Systemic markers of exacerbated chronic obstructive pulmonary disease: how they can help with the decision of whether or not to prescribe antibiotics].
    Soler N
    Arch Bronconeumol; 2008 Nov; 44(11):581-3. PubMed ID: 19007562
    [No Abstract]   [Full Text] [Related]  

  • 2. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
    Martinez FJ; Curtis JL
    Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin-guided antibiotic use in acute respiratory tract infections.
    Bollu M; Marte-Grau AC; Bobba RK
    Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is procalcitonin determination for control of antibiotic therapy in acute respiratory infections of value?].
    Schütz P; Müller B; Briel M
    Praxis (Bern 1994); 2013 Mar; 102(7):413-4. PubMed ID: 23531909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Procalcitonin as a biomarker in infections].
    Christ-Crain M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
    [No Abstract]   [Full Text] [Related]  

  • 7. Procalcitonin-guided antibiotic use in primary care: the ultimate proof still ahead.
    Damoiseaux RA
    Arch Intern Med; 2009 Apr; 169(7):717-8. PubMed ID: 19365004
    [No Abstract]   [Full Text] [Related]  

  • 8. Procalcitonin-guided antibiotic treatment in heart failure.
    Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
    Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332
    [No Abstract]   [Full Text] [Related]  

  • 11. Response by authors.
    Schuetz P; Briel M; Bucher HC; Mueller B;
    Evid Based Child Health; 2013 Jul; 8(4):1374-5. PubMed ID: 24040680
    [No Abstract]   [Full Text] [Related]  

  • 12. How efficient is procalcitonin-guided antibiotic use in acute respiratory tract infections in primary care?
    Brusius AC; Zavascki AP; Fuchs SC
    Arch Intern Med; 2009 Jul; 169(13):1244. PubMed ID: 19597077
    [No Abstract]   [Full Text] [Related]  

  • 13. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
    Tokman S; Schuetz P; Bent S
    Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin-based guidelines and lower respiratory tract infections.
    Cals JW; Metlay JP
    JAMA; 2010 Feb; 303(5):418; author reply 419-20. PubMed ID: 20124534
    [No Abstract]   [Full Text] [Related]  

  • 15. Procalcitonin Testing to Guide Antibiotic Therapy in Acute Upper and Lower Respiratory Tract Infections.
    Schuetz P; Wirz Y; Mueller B
    JAMA; 2018 Mar; 319(9):925-926. PubMed ID: 29509850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease.
    Brightling CE
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S214-9. PubMed ID: 24313775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Cochrane meta-analysis regarding procalcitonin is in accordance with international goals for the use of antibiotics].
    Berg PL; Lindhardt BO
    Ugeskr Laeger; 2013 Dec; 175(50):3093-6. PubMed ID: 24629531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Stannard D
    Crit Care Nurse; 2014 Apr; 34(2):75-6. PubMed ID: 24692469
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
    Christ-Crain M; Müller B
    Eur Respir J; 2007 Sep; 30(3):556-73. PubMed ID: 17766633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of procalcitonin. Valuable for reducing ineffective antibiotic use is debatable].
    Damoiseaux RA
    Ned Tijdschr Geneeskd; 2009 Feb; 153(7):268-9. PubMed ID: 19291938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.